About 400 reports

  • TYPES OF LUNG CANCER
  • GLOBAL LUNG CANCER THERAPEUTICS MARKET

About Lung Cancer Therapeutics Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes...

  • Lung Cancer
  • AstraZeneca PLC
  • Celgene Corporation
  • Eli Lilly & Co.
  • Hoffmann-La Roche Inc.
  • RISK FACTORS AND COMORBIDITIES FOR LUNG CANCER
  • DEFINITIONS USED IN THE AJCC LUNG CANCER STAGING SYSTEM

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently the most common cancer in the world, and is the most common cause of death from cancer worldwide. Of the total lung cancer incident cases, approximately 85% are the non-small cell lung cancer...

  • Lung Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • NSCLC Therapeutics Market, Australia, Age-Specific Incidence Rate (per 100,000),
  • NSCLC Therapeutics Market, Japan, Market Forecast, 2016-2023

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Many countries are facing the challenge of an aging population, and there will be an increased number of people aged 60 and over – a high-risk age range...

  • Lung Cancer
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group

The 2019-2024 World Outlook for Lung Cancer Surgery ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cancer
  • Lung Cancer
  • World
  • Demand

Global Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Cancer
  • Lung Cancer
  • France
  • World
  • Forecast

Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lung Cancer
  • France
  • Germany
  • Italy
  • World

Lung Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Cancer
  • Lung Cancer
  • Pathology
  • World
  • Market Size

The 2019-2024 World Outlook for Non-Small Cell Lung Cancer (NSCLC) Drugs ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cancer
  • Lung Cancer
  • World
  • Demand

Non-Small Cell Lung Cancer (NSCLC) Drugs Market Forecast 2017-2027 ##.

  • Cancer
  • Lung Cancer
  • Pathology
  • World
  • Market Shares
  • Risk Factors and Comorbidities Associated with SCLC
  • 2.3 UPCOMING REPORTS

EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024 Summary Small Cell Lung Cancer (SCLC) is a distinct form of lung cancer that typically initially presents in the central airways before spreading to the submucosa, which leads to the narrowing of airways. SCLC is considered to be highly malignant due...

  • Lung Cancer
  • United States
  • World
  • Forecast
  • GlobalData's company
  • KEY UPDATES IN ALKM+ NSCLC
  • FORECAST UPDATES WILL BE TRIGGERED BY KEY MARKET-IMPACTING EVENTS

Oncogenic and drug sensitive NTRK## rearrangements in lung cancer.

  • Lung Cancer
  • United States
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

Global Lung Cancer Vaccine Market & Pipeline Outlook 2022 ##.

  • Lung Cancer
  • Therapy
  • Vaccine
  • World
  • Forecast

Lung Cancer Phase ## Clinical Trials, 2016 ##.

  • Lung Cancer
  • France
  • United States
  • Market Shares
  • Market Size

Small Cell Lung Cancer Phase ## Clinical Trials, 2016 ##.

  • Lung Cancer
  • France
  • United States
  • Market Shares
  • Market Size

SWOT Analysis in NSCLC, 2016 ## Figure ##: Novartis SWOT Analysis in NSCLC, 2016 ## Figure ##: BI SWOT Analysis in NSCLC, 2016 ## Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players Summary GlobalData has released its pharma report, “Non-Small Cell Lung

  • Cancer
  • Lung Cancer
  • World
  • Company
  • Demand

Lung cancer is classified into three main types: non-small cell lung cancer (NSCLC), small cell lung cancer, and lung carcinoid tumor.

  • Cancer
  • Lung Cancer
  • China
  • World
  • Forecast

Non-small Cell Lung Cancer (NSCLC) Therapeutics Market Analysis Table of Content Chapter ## Research Methodology ##. ## Information Procurement ##. ## Data Analysis Chapter ## Executive Summary ##. ## Market Snapshot Chapter ## Non-small Cell Lung Cancer Therapeut

  • Lung Cancer
  • Therapy
  • United States
  • Forecast
  • Market Size

Non-Small Cell Lung Cancer Phase ## Clinical Trials, 2016 ##.

  • Lung Cancer
  • France
  • United States
  • Market Shares
  • Market Size

Small Cell Lung Cancer - Epidemiology Forecast to 2027 ##.

  • Lung Cancer
  • France
  • Germany
  • Italy
  • Spain

Europe Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lung Cancer
  • Europe
  • France
  • Germany
  • Italy

Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Cancer
  • Lung Cancer
  • Pathology
  • United States
  • Market Shares

Non-Small Cell Lung Cancer - Epidemiology Forecast to 2027 ##.

  • Lung Cancer
  • France
  • Germany
  • Italy
  • Spain

Europe Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lung Cancer
  • Europe
  • France
  • Germany
  • Italy

Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Cancer
  • Lung Cancer
  • Pathology
  • United States
  • Market Shares
  • Lung Cancer (According to ESMO Guidelines)
  • 12.3 SMALL CELL LUNG CANCER MARKET IN APAC REGION

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it also occurs in non-smokers. Lung cancer...

  • Lung Cancer
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Menarini Group
  • Sanofi S.A.
  • 2.2.5 NON-SMALL CELL LUNG CANCER
  • 2.4.5 NON-SMALL CELL LUNG CANCER

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Summary Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against cancer cells. This...

  • Lung Cancer
  • World
  • AbbVie Inc.
  • Aduro BioTech, Inc.
  • Amgen Inc.

Of total lung cancer incident cases, approximately ##% are the non-small cell lung cancer (NSCLC) subtype.

  • Cancer
  • Lung Cancer
  • Pathology
  • Therapy

Of total lung cancer incident cases, approximately ##% are the non-small cell lung cancer (NSCLC) subtype.

  • Cancer
  • Lung Cancer
  • Pathology
  • Therapy

Of total lung cancer incident cases, approximately ##% are the non-small cell lung cancer (NSCLC) subtype.

  • Cancer
  • Lung Cancer
  • Pathology
  • Therapy
  • 4.3.4 China Small Cell Lung Cancer (SCLC) Market by Value
  • CHINA SMALL CELL LUNG CANCER (SCLC) MARKET BY TREATMENT; 2018 (PERCENTAGE, %)

Scope of the Report The report titled “Global PD-1 and PD-L1 Inhibitors Market: Size, Trends and Forecasts (2018-2022)”, provides an in depth analysis of the global PD-1 and PD-L1 inhibitors market by value, by cancer, by treatment, by region, etc. The report also provides a detailed analysis of the China PD-1 and PD-L1...

  • Lung Cancer
  • China
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.